Systemic effects of chronic obstructive pulmonary disease

被引:590
作者
Agustí, AGN
Noguera, A
Sauleda, J
Sala, E
Pons, J
Busquets, X
机构
[1] Hosp Univ Son Dureta, Serv Pneumol, Palma de Mallorca 07014, Spain
[2] Hosp Univ Son Dureta, Anal Clin, Palma de Mallorca 07014, Spain
[3] Hosp Univ Son Dureta, Univ Invest, Palma de Mallorca 07014, Spain
关键词
chronic bronchitis; chronic obstructive pulmonary disease; emphysema; inflammation;
D O I
10.1183/09031936.03.00405703
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Chronic obstructive pulmonary disease (COPD) is characterised by an inappropriate/excessive inflammatory response of the lungs to respiratory pollutants, mainly tobacco smoking. Recently, besides the typical pulmonary pathology of COPD (i.e. chronic bronchitis and emphysema), several effects occurring outside the lungs have been described, the so called systemic effects of COPD. These effects are clinically relevant because they modify and can help in the classification and management of the disease. The present review discusses the following systemic effects of chronic obstructive pulmonary disease: 1) systemic inflammation; 2) nutritional abnormalities and weight loss; 3) skeletal muscle dysfunction; and 4) other potential systemic effects. For each of these, the potential mechanisms and clinical implications are discussed and areas requiring further research are highlighted.
引用
收藏
页码:347 / 360
页数:14
相关论文
共 169 条
  • [1] Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance
    Adams, V
    Jiang, H
    Yu, JT
    Möbius-Winkler, S
    Fiehn, E
    Linke, A
    Weigl, C
    Schuler, G
    Hambrecht, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (04) : 959 - 965
  • [2] Agusti A, 1997, EUR RESP MONOGRAPH, V2, P32
  • [3] CHRONIC PULMONARY-DISEASES - CHRONIC OBSTRUCTIVE PULMONARY-DISEASE AND IDIOPATHIC PULMONARY FIBROSIS
    AGUSTI, AGN
    BARBERA, JA
    [J]. THORAX, 1994, 49 (09) : 924 - 932
  • [4] Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease
    Agustí, AGN
    Sauleda, J
    Miralles, C
    Gomez, C
    Togores, B
    Sala, E
    Batle, S
    Busquets, X
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (04) : 485 - +
  • [5] Agustí AGN, 2001, NOVART FDN SYMP, V234, P242
  • [6] AGUSTI AGN, 2003, IN PRESS EUR RESP MO
  • [7] GENETIC-CONTROL OF THE CD4/CD8 T-CELL RATIO IN HUMANS
    AMADORI, A
    ZAMARCHI, R
    DESILVESTRO, G
    FORZA, G
    CAVATTON, G
    DANIELI, GA
    CLEMENTI, M
    CHIECOBIANCHI, L
    [J]. NATURE MEDICINE, 1995, 1 (12) : 1279 - 1283
  • [8] ACUTE EFFECTS OF INHALED SALBUTAMOL ON THE METABOLIC-RATE OF NORMAL SUBJECTS
    AMOROSO, P
    WILSON, SR
    MOXHAM, J
    PONTE, J
    [J]. THORAX, 1993, 48 (09) : 882 - 885
  • [9] [Anonymous], 1999, AM J RESP CRIT CARE, V159, pS1
  • [10] Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD
    Baarends, EM
    Schols, AMWJ
    Westerterp, KR
    Wouters, EFM
    [J]. THORAX, 1997, 52 (09) : 780 - 785